TCV

Growth Equity

Global technology-focused growth equity firm with extensive health tech portfolio. Co-lead investor in Grow Therapy Series D.

1

Deals Tracked

$150M

Disclosed Capital

Pediatric

Segments

Deals

Date	Company	Round	Amount	Source
Q1 2026	Grow Therapy	Series D Plus	150000000	—